Captrust Financial Advisors Precigen, Inc. Transaction History

Captrust Financial Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 23, 2022	SELL	$1.15 - $2.53 $65 - $144	-57 Reduced 0.66%	8,600 $12,000
Q1 2022 May 16, 2022	SELL	$1.91 - $3.98 $181 - $378	-95 Reduced 1.09%	8,657 $18,000
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $628 - $979	178 Added 2.08%	8,752 $32,000
Q3 2021 Nov 16, 2021	SELL	$4.99 - $6.55 $109 - $144	-22 Reduced 0.26%	8,574 $43,000
Q2 2021 Aug 16, 2021	BUY	$6.24 - $8.22 $8,424 - $11,097	1,350 Added 18.63%	8,596 $56,000
Q1 2021 May 17, 2021	BUY	$6.74 - $10.95 $48,838 - $79,343	7,246 New	7,246 $50,000
Q3 2020 Nov 17, 2020	SELL	$3.5 - $6.2 $199 - $353	-57 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.16 - $5.46 $123 - $311	57 New	57 $0

144

160M

136K

4.8K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $373M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.